A study to find out more about the effect of AMG 181 in people with moderate to severe Crohn's Disease

Mise à jour : Il y a 5 ans
Référence : EUCTR2012-000529-31

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the efficacy of AMG 181 as measured by the proportion of subjects achieving Crohn’s Disease Activity Index (CDAI) remission (CDAI < 150) at week 8


Critère d'inclusion

  • Moderate to Severe Crohn's Disease